5-HT2C receptor agonist

From WikiMD's WELLNESSPEDIA

5-HT2C_receptor_pathway A 5-HT2C receptor agonist is a type of drug that activates the 5-HT2C receptor. The 5-HT2C receptor is a subtype of the 5-HT receptor which is directly responsive to the neurotransmitter serotonin.

Mechanism of Action[edit]

5-HT2C receptor agonists work by mimicking the action of serotonin at the 5-HT2C receptor. This results in increased activity of the receptor, which can lead to a variety of physiological effects. The exact effects depend on the specific drug and the area of the brain in which it is acting.

Therapeutic Uses[edit]

5-HT2C receptor agonists have potential therapeutic uses in a variety of conditions. These include obesity, schizophrenia, depression, and drug addiction. Some 5-HT2C receptor agonists are also used in the treatment of migraines and anxiety disorders.

Examples[edit]

Some examples of 5-HT2C receptor agonists include Lorcaserin, which is used for weight loss, and Agomelatine, which is used for the treatment of major depressive disorder.

Side Effects[edit]

Like all drugs, 5-HT2C receptor agonists can have side effects. These can include nausea, dizziness, and sleep disturbances. However, the side effects can vary greatly depending on the specific drug and the individual taking it.

See Also[edit]

References[edit]


Drug design
Steps in design
Case studies of discovery
and development of drug classes
* 5α-Reductase inhibitors





Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=5-HT2C_receptor_agonist&oldid=6622554"